Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$250.00
Provider: GlobalData
$250.00
Provider: Union Securities
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Diagnos Inc Announces the Creation of Indian Subsidiary and the Opening of an Office in India


Wednesday, 18 Sep 2013 09:30am EDT 

DIAGNOS Inc announced the Creation of Indian Subsidiary and the Opening of an Office in Mumbai, India, to support and coordinate deployment and usage of CARA in India. To execute on the LOI signed with a global pharmaceutical company in India, announced on September 4th 2013, Diagnos has created a local subsidiary: Diagnos Healthcare (india) Private Limited. The subsidiary is incorporated in Mumbai, Maharashtra, India, under the Indian Companies Act, as a private limited company approved by Anuradha Bhaskar Athavale, Deputy Registrar of Companies. 

Company Quote

0.065
-0.0050 -7.14%
23 Jul 2014